Abstract
Biological Implants report analyzes the market for biological implant
procedures. The total biological implants market is analyzed by tissue/muscle;
origin, and mode of administration at global level and for each of the
geographic regions - North America, Europe, Asia-Pacific and Rest of World.
The biological implants market is segmented by Tissue/Muscle into Soft Tissue,
Orthopedic, Cardiovascular and Other (includes Dental, Ophthalmic, and
Urologic); by Origin into Allograft, and Xenograft; and by Mode of
Administration into Injectable and Surgical.
Business profiles of 27 major companies are discussed in the report. The
report serves as a guide to global biological implants industry covering 164
companies that are engaged in biological implants' processing, R&D, storage,
banking, discovery, testing and supply of products and services. Major
Contract Research Organizations and Universities serving the industry are also
covered in the Corporate Directory section of this report. Information related
to recent product releases, product developments, partnerships,
collaborations, mergers and acquisitions, ethical issues, regulatory affairs,
and other areas of concern is also covered in the report. Projections and
estimates are graphically illustrated by geographic region with exclusive
graphical representations provided for 241 exhibits.